OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Substance Abuse Treatment is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study	81
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder	61
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?	61
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	58
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up	56
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data	55
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts	54
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders	52
C2: editorial board	49
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study	41
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation	40
Education and careers were our way out	35
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments	34
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	33
Emergency department interventions for opioid use disorder: A synthesis of emerging models	32
Can nicotine replacement therapy be personalized? A statistical learning analysis	31
A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior	31
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam	31
Facing the future of substance use disorders treatment in Vietnam – A case study for international development and cooperation	28
Association between industry sponsorship and author conflicts of interest with outcomes of systematic reviews and meta-analyses of interventions for opioid use disorder	28
Connecting and disconnecting: Experiences of people with opioid use disorder in intensive outpatient treatment	27
Using machine learning to examine predictors of treatment goal change among individuals seeking treatment for alcohol use disorder	27
Adapting methadone inductions to the fentanyl era	27
Tobacco smoking and nicotine dependence among patients with respiratory diseases in Vietnam: Status and correlated factors	27
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform	27

A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment	26
Improving geographic access to methadone clinics	26
Frequency and recency of non-medical opioid use and death due to overdose or suicide among individuals assessed for risky substance use: A national registry study in Sweden	25
Drug court utilization of medications for opioid use disorder in high opioid mortality communities	25
The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives	25
National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness	25
Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX	24
Addressing adolescent substance use in an urban pediatric federally qualified health center	24
Mobile-based brief interventions targeting cannabis-impaired driving among youth: A Delphi study	24
The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs	24
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder	23
Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes	22
Latent class analysis of self-reported substance use during incarceration: Gender differences and associations with emotional distress and aggressiveness	22
Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon	22
Scoping review of interventions to link individuals to substance use services at discharge from jail	22
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine	21
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program	21
The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction	21
An exploration of thriving over time in recovery	21
Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers	20
C2: editorial board	20
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–2020	20
Corrigendum to “Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study” [Journal of Substance Abuse Treatment 130 (2021) 108415]	20
Contingency management for treatment attendance: A meta-analysis	19
Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey	19
Racial disparities in linkage to care among patients with substance use disorders	19
Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder	19
Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals	19
TOC (update)	18
Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities	18
C2: editorial board	18
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19	18
Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?	17
C2: editorial board	17
Developing a cascade of care for opioid use disorder among individuals in jail	17
Mobile low-threshold buprenorphine integrated with infectious disease services	17
Alcohol and drug use among bartenders: An at risk population?	17
Patient-centered primary care and receipt of evidence-based alcohol-related care in the national Veterans Health Administration	16
Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network	15
Client attitudes toward virtual treatment court	15
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study	15
Associations between relationship quality and treatment-related stress among couples receiving methadone for opioid use disorder	15
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder	15
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care	15